Journal of
Public Health and Epidemiology

  • Abbreviation: J. Public Health Epidemiol.
  • Language: English
  • ISSN: 2141-2316
  • DOI: 10.5897/JPHE
  • Start Year: 2009
  • Published Articles: 523

Full Length Research Paper

Survival and predictors of mortality from multidrug resistant tuberculosis (MDR-TB) among patients treated at MDR-TB Referal Hospitals in Ethiopia: A retrospective cohort study

Mulugeta Shegaze Shimbre
  • Mulugeta Shegaze Shimbre
  • Department of Public Health, College of Medicine and Health Sciences, Arba Minch University, Ethiopia.
  • Google Scholar
Tamiru Shibru Degaga
  • Tamiru Shibru Degaga
  • Department of Internal Medicine, College of Medicine Health Sciences, Arba Minch University, Ethiopia.
  • Google Scholar
Sultan Hussen Hebo
  • Sultan Hussen Hebo
  • Department of Public Health, College of Medicine and Health Sciences, Arba Minch University, Ethiopia.
  • Google Scholar
Zerihun Zerdo
  • Zerihun Zerdo
  • Department of Medical Laboratory Sciences, College of Medicine Health Sciences, Arba Minch University, Ethiopia.
  • Google Scholar
Tadele Girum
  • Tadele Girum
  • Department of Public health, College of Medicine and Health Sciences, Wolkite University, Wolkite, Ethiopia.
  • Google Scholar
Teklu Teshome
  • Teklu Teshome
  • Department of Biomedical Sciences, School of Medicine, Arba Minch University, Arba Minch Ethiopia.
  • Google Scholar


  •  Received: 01 March 2019
  •  Accepted: 05 July 2019
  •  Published: 31 January 2020

Abstract

The extent and burden of MDR-TB varies significantly from country to country. In Africa, fewer than half of patients receiving therapy for multidrug-resistant TB (MDR TB) are successfully treated. Even though MDR-TB treatment was started in 2009 survival of MDR-TB treatment particularly of adverse treatment outcome is not studied in national level.  Institution based retrospective cohort study was conducted at randomly selected four treatment Initiative Centers (TIC) & referral hospitals in Ethiopia. Data was collected using standardized checklist by trained professionals through reviewing records of all patients ever enrolled. Cox- proportional hazard regression model was built of the 494 records reviewed, 462 met the inclusion criteria. These patients were followed for 202250 person-day of observation; during the follow up period 38 (8.2%) patients were died making overall incidence density rate of 6.79 (95% CI=5.42-8.78) per 100 Person year. Survival at the end of 1st and 4th month was 98.2% and 92.3% respectively, while the overall mean survival time was 24.82(95%CI=22.8-25.72) months. Drugs side effect 3 (95 % CI [2.5-4.3, medical diagnosis other than TB 3.3 (95 % CI [1.7-5.6], HIV sero-status 2.7 (95 % CI [3.4-9.11] and bigger base line body were independently and significantly predicted mortality of MDR-TB patients. The incidence of death and treatment outcomes was in acceptable ranges, yet it needs due attention. Intervention to further reduce deaths has to focus on patients with co-morbidities, HIV, adverse effect and smaller base line body weight.

Key words:  'MDR-TB, Survivable, Mortality, Ethiopia.